|
Volumn 15, Issue 1, 2004, Pages 53-55
|
Paraneoplastic cholestasis associated with prostate carcinoma
|
Author keywords
Obstructive jaundice; Paraneoplastic syndromes; Prostate carcinoma
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ALBUMIN;
ALKALINE PHOSPHATASE;
ANTINEOPLASTIC AGENT;
ANTINUCLEAR ANTIBODY;
ASPARTATE AMINOTRANSFERASE;
BICALUTAMIDE;
BILIRUBIN;
CHLORIDE;
CREATININE;
CYPROTERONE ACETATE;
CYTOKINE;
FLUTAMIDE;
GAMMA GLUTAMYLTRANSFERASE;
GLUCOSE;
GOSERELIN;
HEMOGLOBIN;
MITOCHONDRION ANTIBODY;
PLASMA PROTEIN;
POTASSIUM;
PROSTATE SPECIFIC ANTIGEN;
SODIUM;
TECHNETIUM 99M;
ZOLEDRONIC ACID;
AGED;
ARTICLE;
BONE METASTASIS;
BONE PAIN;
CANCER CHEMOTHERAPY;
CANCER HORMONE THERAPY;
CANCER REGRESSION;
CASE REPORT;
CHOLESTASIS;
CLINICAL FEATURE;
CLINICAL PROTOCOL;
CYTOKINE RELEASE;
DISEASE ASSOCIATION;
DRUG DOSE REGIMEN;
FOLLOW UP;
HEPATITIS;
HISTOPATHOLOGY;
HUMAN;
HUMAN TISSUE;
JAUNDICE;
LIVER BIOPSY;
LIVER METASTASIS;
MALE;
OBSTRUCTIVE JAUNDICE;
OUTCOMES RESEARCH;
PARANEOPLASTIC SYNDROME;
PATHOPHYSIOLOGY;
PROSTATE BIOPSY;
PROSTATE CARCINOMA;
ADENOCARCINOMA;
AGED;
ANDROGEN ANTAGONISTS;
BIOPSY, NEEDLE;
CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE;
CHOLESTASIS, INTRAHEPATIC;
DRUG THERAPY, COMBINATION;
HUMANS;
IMMUNOHISTOCHEMISTRY;
JAUNDICE, OBSTRUCTIVE;
LIVER FUNCTION TESTS;
MALE;
PARANEOPLASTIC SYNDROMES;
PROGNOSIS;
PROSTATIC NEOPLASMS;
RISK ASSESSMENT;
TREATMENT OUTCOME;
|
EID: 2942561961
PISSN: 13004948
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (20)
|
References (9)
|